ClearNote Health (ClearNote) is a biotechnology company that develops non-invasive tests to detect pancreatic and ovarian cancer. The company utilizes a 5hmC-based proprietary technology platform to provide a deep understanding of the underpinnings of cancer development. ClearNote non-invasive liquid biopsy technologies detect changes in specific organs, identify biological activity and gene expression, improve therapy selection and safety monitoring and evaluate individual’s organ systems and biological functions. It also carries out research and development, clinical trials and tests. The company works in collaboration with leading research institutions and academic and pharmaceutical industry collaborators. It operates offices in San Diego and San Mateo, the US. ClearNote is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ClearNote Health
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- ClearNote Health Company Overview
- ClearNote Health Company Snapshot
- ClearNote Health Pipeline Products and Ongoing Clinical Trials Overview
- ClearNote Health - Pipeline Analysis Overview
- ClearNote Health - Key Facts
- ClearNote Health - Major Products and Services
- ClearNote Health Pipeline Products by Development Stage
- ClearNote Health Pipeline Products Overview
- ClearNote Health Pancreatic Cancer Detection Test
- ClearNote Health Pancreatic Cancer Detection Test Product Overview
- Multi-Cancer Detection Test
- Multi-Cancer Detection Test Product Overview
- Non-Small Cell Lung Cancer Detection Test
- Non-Small Cell Lung Cancer Detection Test Product Overview
- ClearNote Health - Key Competitors
- ClearNote Health - Key Employees
- ClearNote Health - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ClearNote Health, Recent Developments
- Mar 12, 2025: ClearNote Health’s Avantect Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks
- Feb 18, 2025: ClearNote Health Earns Approval for Avantect Pancreatic Cancer Test from New York State Department of Health
- Jan 07, 2025: ClearNote Health’s Avantect Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
- Dec 19, 2024: ClearNote and Southampton researchers partner for pancreatic cancer test study
- Oct 31, 2024: Avantect Pancreatic Cancer Test Cost-Effective When Used as a Surveillance Tool in High-Risk Patients Newly Diagnosed with Diabetes
- Sep 26, 2024: Avantect Ovarian Cancer Test Receives CPT Code and Preliminary Payment Determination from the Centers for Medicare and Medicaid Services
- Mar 26, 2024: New Data Show ClearNote Health’s Epigenomic Platform Provides a Novel Tissue-Free, Liquid Biopsy-Based Approach to Identify Potential Predictive Biomarker Candidates to Radioligand Therapy Response in Patients With Pancreatic Neuroendocrine Tumors
- Jan 30, 2024: Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
- Jan 16, 2024: ClearNote Health Announces New Proprietary Approach for Predicting Immunotherapy Treatment Response in Non-Small Cell Lung Cancer Using Only Blood
- May 08, 2023: Study validating ClearNote Health’s Avantect pancreatic cancer detection test published in the Journal Clinical Gastroenterology and Hepatology
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- ClearNote Health Pipeline Products and Ongoing Clinical Trials Overview
- ClearNote Health Pipeline Products by Equipment Type
- ClearNote Health Pipeline Products by Indication
- ClearNote Health, Key Facts
- ClearNote Health, Major Products and Services
- ClearNote Health Number of Pipeline Products by Development Stage
- ClearNote Health Pipeline Products Summary by Development Stage
- ClearNote Health Pancreatic Cancer Detection Test - Product Status
- ClearNote Health Pancreatic Cancer Detection Test - Product Description
- Multi-Cancer Detection Test - Product Status
- Multi-Cancer Detection Test - Product Description
- Non-Small Cell Lung Cancer Detection Test - Product Status
- Non-Small Cell Lung Cancer Detection Test - Product Description
- ClearNote Health, Key Employees
- ClearNote Health, Other Locations
- Glossary
- ClearNote Health Pipeline Products by Equipment Type
- ClearNote Health Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- SkinIO Inc
- Grail LLC
- Sorenson Genomics LLC
- Biocept Inc
- Pathway Genomics Corp
- Circulogene Theranostics Inc
